inSoma Bio

inSoma Bio

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.insomabio.com

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$5.52M

Momentum Score

50 /100

Company Overview

inSoma Bio is a biotechnology company that develops bioengineered reconstructive biomaterials for plastic and reconstructive surgery. The company's core technology involves injectable, protein-based scaffolds that are designed to mimic human tissue and provide structural support for tissue integration. These materials have a thermal-switch, activating at body temperature to form a scaffold, which can be combined with a patient's own fat tissue for procedures like breast and facial reconstruction. This approach aims to offer a safer alternative to synthetic implants or fillers by promoting natural tissue repair. Founded in 2018 and based in Durham, North Carolina, the company's technology originated from research conducted at Duke University.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

injectable biomaterialprotein-based scaffoldsoft tissue reconstructionbio-scaffoldregenerative medicinetissue engineeringreconstructive surgerybreast reconstructionfat graftingfacial reconstructionthermally-responsive biomaterialsoft tissue augmentationimplant alternativebiotechnologymedical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inSoma Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

inSoma Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
SeedNov 1, 2023
GrantSep 1, 2023
GrantDec 15, 2022
GrantDec 15, 2022
Seed
Aug 22, 2020

inSoma Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 433% MoM.

inSoma Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

inSoma Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about inSoma Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range14
Year Founded2018
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.